ArriVent BioPharma Prices Upsized IPO, Aims to Raise $175 Million
NEWTOWN SQUARE, PA — ArriVent BioPharma Inc., a clinical-stage biopharmaceutical company, announced on Friday the pricing of its upsized initial public offering (IPO). The company will issue 9,722,222 shares of …
ArriVent BioPharma Prices Upsized IPO, Aims to Raise $175 Million Read More